N 6 -adenosine methylation (m 6 A) is the most common posttranscriptional RNA modification in mammalian cells. We found that most transcripts encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV) genome undergo m 6 A modification. The levels of m 6 A-modified mRNAs increased substantially upon stimulation for lytic replication. The blockage of m 6 A inhibited splicing of the pre-mRNA encoding the replication transcription activator (RTA), a key KSHV lytic switch protein, and halted viral lytic replication. We identified several m 6 A sites in RTA pre-mRNA crucial for splicing through interactions with YTH domain containing 1 (YTHDC1), an m 6 A nuclear reader protein, in conjunction with serine/arginine-rich splicing factor 3 (SRSF3) and SRSF10. Interestingly, RTA induced m 6 A and enhanced its own premRNA splicing. Our results not only demonstrate an essential role of m 6 A in regulating RTA pre-mRNA splicing but also suggest that KSHV has evolved a mechanism to manipulate the host m 6 A machinery to its advantage in promoting lytic replication.IMPORTANCE KSHV productive lytic replication plays a pivotal role in the initiation and progression of Kaposi's sarcoma tumors. Previous studies suggested that the KSHV switch from latency to lytic replication is primarily controlled at the chromatin level through histone and DNA modifications. The present work reports for the first time that KSHV genome-encoded mRNAs undergo m 6 A modification, which represents a new mechanism at the posttranscriptional level in the control of viral replication.KEYWORDS KSHV, N 6 -adenosine methylation, RNA splicing, lytic replication G ene expression is controlled not only at the chromatin level through histone and DNA modifications but also at the posttranscriptional level through RNA modifications. N 6 -adenosine methylation (m 6 A) is the most abundant RNA modification found in ϳ25% of RNA species in mammalian cells (1, 2). Despite its discovery decades ago (3-7), the biochemical pathways responsible for m 6 A and the biological functions of this process were not fully defined until very recently (8-10). Three methyltransferases, including methyltransferase-like 3 (METTL3), methyltransferase-like 14 (METTL14), and Wilms' tumor 1-associated protein (WTAP), act as m 6 A writers and catalyze RNA m 6 A at specific sites with the consensus sequence [(G/A)GAC, where the underlined adenosine is the methylation site] (11, 12). Two demethylases, fat mass-and obesity-associated protein (FTO) and AlkB homolog 5 (ALKBH5), both of which act as m 6 A erasers, reverse this process (13-17). Most m 6 A sites are located near the transcription start sites, exonic regions flanking splicing sites, stop codons, and the 3= untranslated region (3= UTR) (1,